Cipla partners with Eli Lilly to market diabetes drug Basaglar in India

[lavonnebatlinerr]

Moneycontrolcom
Drug firm Cipla today said it has partnered with Eli Lilly to market and distribute Lillys insulin glargine injection, Basaglar, in India.